Research Advances in Adenomyosis-Related Signaling Pathways and Promising Targets
Biomolecules · 04.11.2024 · 14 (11) · 1402
DOI: 10.3390/biom14111402 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.11.2024. Verfasst von Hongyu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Adenomyosis, Signal Transduction. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province, Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital, Talent introduction Project of the Second Hospital of Lanzhou University.
Abstract (Originalsprache)
Adenomyosis is a benign gynecological condition characterized by the proliferation of the endometrial stroma and glands into the myometrium, uterine volume enlargement, and peripheral smooth muscle hypertrophy. The typical clinical symptoms include chronic pelvic pain, abnormal uterine bleeding, and subfertility, all of which significantly impact quality of life. There are no effective prevention or treatment strategies for adenomyosis, partly due to a limited understanding of the pathological mechanisms underlying the initiation and progression of the disease. Given that signaling pathways play a crucial role in the development of adenomyosis, a better understanding of these signaling pathways is essential for identifying therapeutic targets and advancing drug development. The occurrence and progression of adenomyosis are closely linked to various underlying pathophysiological mechanisms, including proliferation, migration, invasion, fibrosis, angiogenesis, inflammation, oxidative stress, immune response, and epigenetic changes. This review summarizes the signaling pathways and targets associated with the pathogenesis of adenomyosis, including CXCL/CXCR, NLRP3, NF-κB, TGF-β/smad, VEGF, Hippo/YAP, PI3K/Akt/mTOR, JAK/STAT, and other relevant pathways. In addition, it identifies promising future targets for the development of adenomyosis treatment, such as m6A, GSK3β, sphks, etc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730000, China.
- Departmemt of Urology, The First People's Hospital of Longnan, Longnan 742500, China.
Förderung
- Natural Science Foundation of Gansu Province
- Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
- Talent introduction Project of the Second Hospital of Lanzhou University
- Corporation Science Foundation of Gansu Province
Zitieren
APA
Zhang, H., Li, C., Li, W., Xin, W., & Qin, T. (2024). Research Advances in Adenomyosis-Related Signaling Pathways and Promising Targets. Biomolecules, 14(11), 1402. https://doi.org/10.3390/biom14111402
Vancouver
Zhang H, Li C, Li W, Xin W, Qin T. Research Advances in Adenomyosis-Related Signaling Pathways and Promising Targets. Biomolecules. 2024;14(11):1402. doi:10.3390/biom14111402
BibTeX
@article{Zhang2024,
author = {Zhang, Hongyu and Li, Chaoming and Li, Wenyan and Xin, Wenhu and Qin, Tiansheng},
title = {Research Advances in Adenomyosis-Related Signaling Pathways and Promising Targets},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {11},
pages = {1402},
doi = {10.3390/biom14111402}
}
EUVIMED